291 related articles for article (PubMed ID: 21761204)
1. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.
Trembley JH; Unger GM; Tobolt DK; Korman VL; Wang G; Ahmad KA; Slaton JW; Kren BT; Ahmed K
Mol Cell Biochem; 2011 Oct; 356(1-2):21-35. PubMed ID: 21761204
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model.
Slaton JW; Unger GM; Sloper DT; Davis AT; Ahmed K
Mol Cancer Res; 2004 Dec; 2(12):712-21. PubMed ID: 15634760
[TBL] [Abstract][Full Text] [Related]
3. CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.
Brown MS; Diallo OT; Hu M; Ehsanian R; Yang X; Arun P; Lu H; Korman V; Unger G; Ahmed K; Van Waes C; Chen Z
Clin Cancer Res; 2010 Apr; 16(8):2295-307. PubMed ID: 20371694
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of CK2 induces apoptosis in cancer cells--a potential approach to cancer therapy.
Wang G; Unger G; Ahmad KA; Slaton JW; Ahmed K
Mol Cell Biochem; 2005 Jun; 274(1-2):77-84. PubMed ID: 16342410
[TBL] [Abstract][Full Text] [Related]
5. Intracellular hydrogen peroxide production is an upstream event in apoptosis induced by down-regulation of casein kinase 2 in prostate cancer cells.
Ahmad KA; Wang G; Ahmed K
Mol Cancer Res; 2006 May; 4(5):331-8. PubMed ID: 16687488
[TBL] [Abstract][Full Text] [Related]
6. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
Bollacke A; Nienberg C; Borgne ML; Jose J
J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
[TBL] [Abstract][Full Text] [Related]
7. Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells.
Kreutzer JN; Ruzzene M; Guerra B
BMC Cancer; 2010 Aug; 10():440. PubMed ID: 20718998
[TBL] [Abstract][Full Text] [Related]
8. Differential localization of alpha' and beta subunits of protein kinase CK2 during rat spermatogenesis.
Alvarado-Díaz CP; Tapia JC; Antonelli M; Moreno RD
Cell Tissue Res; 2009 Oct; 338(1):139-49. PubMed ID: 19711102
[TBL] [Abstract][Full Text] [Related]
9. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
10. Targeting CK2 for cancer therapy.
Ahmad KA; Wang G; Slaton J; Unger G; Ahmed K
Anticancer Drugs; 2005 Nov; 16(10):1037-43. PubMed ID: 16222144
[TBL] [Abstract][Full Text] [Related]
11. The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development.
Lou DY; Dominguez I; Toselli P; Landesman-Bollag E; O'Brien C; Seldin DC
Mol Cell Biol; 2008 Jan; 28(1):131-9. PubMed ID: 17954558
[TBL] [Abstract][Full Text] [Related]
12. Up-Regulation of the Alpha Prime Subunit of Protein Kinase CK2 as a Marker of Fast Proliferation in GL261 Cultured Cells.
Villamañan L; Alcaraz E; Pinna LA; Ruzzene M; Itarte E; Arús C; Plana M; Candiota AP
Pathol Oncol Res; 2019 Oct; 25(4):1659-1663. PubMed ID: 30607803
[TBL] [Abstract][Full Text] [Related]
13. Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.
Zheng Y; McFarland BC; Drygin D; Yu H; Bellis SL; Kim H; Bredel M; Benveniste EN
Clin Cancer Res; 2013 Dec; 19(23):6484-94. PubMed ID: 24036851
[TBL] [Abstract][Full Text] [Related]
14. CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.
Ahmed K; Kren BT; Abedin MJ; Vogel RI; Shaughnessy DP; Nacusi L; Korman VL; Li Y; Dehm SM; Zimmerman CL; Niehans GA; Unger GM; Trembley JH
Oncotarget; 2016 Sep; 7(38):61789-61805. PubMed ID: 27557516
[TBL] [Abstract][Full Text] [Related]
15. KIF5C: a new binding partner for protein kinase CK2 with a preference for the CK2alpha' subunit.
Schäfer B; Götz C; Dudek J; Hessenauer A; Matti U; Montenarh M
Cell Mol Life Sci; 2009 Jan; 66(2):339-49. PubMed ID: 19011756
[TBL] [Abstract][Full Text] [Related]
16. Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells.
Yao K; Youn H; Gao X; Huang B; Zhou F; Li B; Han H
Prostate; 2012 Sep; 72(13):1423-30. PubMed ID: 22290244
[TBL] [Abstract][Full Text] [Related]
17. CK2 kinase activity but not its binding to CK2 promoter regions is implicated in the regulation of CK2α and CK2β gene expressions.
Lupp S; Gumhold C; Ampofo E; Montenarh M; Rother K
Mol Cell Biochem; 2013 Dec; 384(1-2):71-82. PubMed ID: 23963994
[TBL] [Abstract][Full Text] [Related]
18. NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.
Li X; Guan B; Maghami S; Bieberich CJ
Mol Cell Biol; 2006 Apr; 26(8):3008-17. PubMed ID: 16581776
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
20. Role of protein kinase CK2 in the regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells.
Wang G; Ahmad KA; Ahmed K
Cancer Res; 2006 Feb; 66(4):2242-9. PubMed ID: 16489027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
